New trial subscription to NEJM Evidence

The library has set up a trial subscription to NEJM Evidence until April 2, 2022.
NEJM Evidence is a new monthly, peer-reviewed digital journal from NEJM Group, which also publishes the New England Journal of Medicine and NEJM Catalyst Innovations in Care Delivery. NEJM Evidence presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making. In addition to bringing original research, reviews, case studies, and explanatory videos from the front lines of medicine, NEJM Evidence also gives readers a behind-the-scenes view of clinical trials from the perspectives of both the patient and the clinical trial investigator.

Stay current with the latest in clinical trial design and clinical decision-making by creating a free personal NEJM Group account that allows you to do the following:

• Gain one-click institutional remote access to NEJM Evidence — anytime, anywhere, and from any device

• Sign up for the This Week email alert, featuring the monthly Table of Contents plus weekly updates on continuously published articles

• Save articles, keywords, and search results at evidence.nejm.org

Please let us know what you think of NEJM Evidence, you can send an email to the Central Medical Library: cmb umcg.nl